Cyclophilin A: Promising new target in cardiovascular therapy

Kimio Satoh, Hiroaki Shimokawa, Bradford C. Berk

Research output: Contribution to journalReview articlepeer-review

80 Citations (Scopus)


Cyclophilin A (CyPA) has been studied as a multifunctional protein that is upregulated in a variety of inflammatory conditions, such as rheumatoid arthritis, autoimmune disease, and cancer. CyPA has been classified as an immunophilin and has a variety of intracellular functions, including intracellular signaling, protein trafficking, and the regulation of other proteins activity. Besides its intracellular functions, CyPA is a secreted molecule that has a physiological and pathological role in cardiovascular diseases, making it a potential biomarker and mediator in cardiovascular diseases, such as vascular stenosis, atherosclerosis, and abdominal aortic aneurysms.

Original languageEnglish
Pages (from-to)2249-2256
Number of pages8
JournalCirculation Journal
Issue number11
Publication statusPublished - 2010 Nov


  • Immunophilin
  • Matrix metalloproteinase
  • Reactive oxygen species
  • Remodeling
  • Vasculature

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Cyclophilin A: Promising new target in cardiovascular therapy'. Together they form a unique fingerprint.

Cite this